Literature DB >> 34109442

ADHD should be considered in adolescents with type 1 diabetes and poor metabolic control.

Charlotte Nylander1,2, Elisabeth Fernell3.   

Abstract

Entities:  

Keywords:  ADHD; Attention-deficit/hyperactivity disorder; Executive functions; Type 1 diabetes

Mesh：

Year:  2021        PMID： 34109442     DOI： 10.1007/s00125-021-05493-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  5 in total

1.  Self- and parent-reported executive problems in adolescents with type 1 diabetes are associated with poor metabolic control and low physical activity.

Authors:  Charlotte Nylander; Ylva Tindberg; Josephine Haas; Ingemar Swenne; Torun Torbjörnsdotter; Karin Åkesson; Eva Örtqvist; Jan Gustafsson; Elisabeth Fernell
Journal:  Pediatr Diabetes       Date:  2017-03-20       Impact factor: 4.866

2.  Previously undiagnosed attention-deficit/hyperactivity disorder associated with poor metabolic control in adolescents with type 1 diabetes.

Authors:  C Nylander; K Lindström; N Khalifa; E Fernell
Journal:  Pediatr Diabetes       Date:  2018-03-24       Impact factor: 4.866

3.  Psychiatric morbidity and health outcome in Type 1 diabetes--perspectives from a prospective longitudinal study.

Authors:  E A Northam; L K Matthews; P J Anderson; F J Cameron; G A Werther
Journal:  Diabet Med       Date:  2005-02       Impact factor: 4.359

Review 4.  The effect of type 1 diabetes on the developing brain.

Authors:  Fergus J Cameron; Elisabeth A Northam; Christopher M Ryan
Journal:  Lancet Child Adolesc Health       Date:  2019-04-12

5.  Poor glycaemic control is associated with increased risk of neurodevelopmental disorders in childhood-onset type 1 diabetes: a population-based cohort study.

Authors:  Shengxin Liu; Ralf Kuja-Halkola; Henrik Larsson; Paul Lichtenstein; Jonas F Ludvigsson; Ann-Marie Svensson; Soffia Gudbjörnsdottir; Magnus Tideman; Eva Serlachius; Agnieszka Butwicka
Journal:  Diabetologia       Date:  2021-01-16       Impact factor: 10.122
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.